Project Grant R01CA291888
Award Date
7/1/24
Completion Date
8/31/29
Dollars Obligated
$1.1M
Federal Agency
National Cancer Institute
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This $578,467 Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) to Duke University is for a randomized controlled trial testing the efficacy of a telehealth-delivered psychosocial intervention called ENGAGE. The intervention aims to decrease symptom interference (pain, fatigue, distress) and improve quality of life in patients with advanced cancer receiving care in medically underserved areas. The 5-year study will randomize 190 patients to receive...
The National Cancer Institute (NCI) awarded a $664,259 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Duke University. The grant supports the development and evaluation of a digital health intervention called AYA STEPS (Symptom Management and Transitioning to Engagement with Post-Treatment Care for Adolescent and Young Adult (AYA) Cancer Survivors). The AYA STEPS intervention is designed to help AYA cancer survivors, aged 15-39 at diagnosis, manage their...
This federal Project Grant award from the National Cancer Institute under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) provides $746,926 to Brigham & Women's Hospital Inc. to assess the efficacy of a phone-delivered positive psychological intervention (PATH) for improving anxiety, depression symptoms, and quality of life in hematopoietic stem cell transplantation (HSCT) survivors. The 5-year study will be conducted at multiple sites, including Moffitt...
The National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.398 - Cancer Research Manpower) valued at $173,997 to Duke University on Jul 9, 2024. The grant supports a pilot randomized controlled trial to extend the NITE2DAY intervention to the inpatient setting for hematologic cancer patients. NITE2DAY+ is a self-paced mobile app intervention that provides mindfulness meditations, sleep education, and behavioral strategies to improve insomnia, fatigue, distress, and pain symptoms during...
The National Cancer Institute (NCI) awarded a $656,014 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The Ohio State University to conduct a randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients in underserved rural communities. The goal is to improve sleep difficulties, worry-anxiety, depression, and fatigue symptoms, which commonly occur as a cluster in advanced cancer patients and contribute to functional...
This is a Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research federal grant program (CFDA 93.393). The $591,372 award will fund a multi-site randomized controlled trial of a novel digital application called DREAMLAND to improve quality of life and psychological outcomes for patients with acute myeloid leukemia (AML) undergoing intensive chemotherapy. The trial will be conducted across three sites - Massachusetts General Hospital, Duke...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $599,339 aims to conduct a randomized trial evaluating the efficacy of a multidisciplinary telehealth intervention (HORIZONS) compared to usual care for improving quality of life, psychological distress, symptoms, coping, and self-efficacy in hematopoietic stem cell transplant survivors with chronic graft-versus-host disease. The study will be conducted at the University of...
The National Cancer Institute awarded a $130,001 Project Grant (CFDA 93.398 - Cancer Research Manpower) to Northwestern University to examine physical activity promotion intervention outcomes, barriers, and facilitators in breast cancer survivors with fatigue. The study aims to explore the effects of different physical activity promotion intervention components in this population and assess multi-level stakeholder preferences to inform future mHealth intervention development. The research will...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $671,757 to Virginia Commonwealth University (VCU) to conduct a clinical trial evaluating a tailored exercise intervention for preserving exercise capacity, left ventricular function, and health-related quality of life in women receiving anthracycline-based chemotherapy for breast cancer. The 5-year study, titled "Supportive Tailored Exercise...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $602,526 to The General Hospital Corporation (Massachusetts General Hospital) to conduct a multi-site randomized controlled trial of a novel digital application called SHIFT. The goal is to examine the efficacy of SHIFT for improving sexual health outcomes, quality of life, and psychological outcomes in hematopoietic stem cell transplant survivors. The award includes...